The Latest Breaking News from Breast Cancer

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…

The death of Australian superstar Olivia Newton-John has drawn attention to an often misunderstood stage of breast cancer — metastatic breast cancer.

What outsiders may not recognize is the mental strength and bravery required not only to live with cancer, but also thrive amid a life-changing condition.

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

From the partner who vanished at sea and her daughter’s battle with anorexia to her life-changing charity work, Giulia Crouch looks back at the life and legacy of a Hollywood great

The Grease star had lived with breast cancer since her diagnosis at the age of 43.

After being diagnosed with breast cancer in 1992, singer and actress Olivia Newton-John spent the next 30 years crusading for awareness, support and cures.

The actress revealed her diagnosis as she paid an emotional tribute to Olivia Newton-John

The actress shared the news as she paid tribute to Oliva Newton-John